A groundbreaking treatment targeting the RAS gene is moving into human trials. This innovative approach may treat various cancers while minimizing side effects, offering new hope for patients.
Elissa Kalver, diagnosed with HER2-positive metastatic breast cancer at 34, shares her inspiring journey through aggressive treatments, clinical trials, and living life to the fullest despite her diagnosis.
